#MedNews - Adding a conventional synthetic #DMARD to first-line systemic corticosteroid therapy may reduce treatment failure in patients with nonanterior sarcoidosis-associated #uveitis. Full story 👉 buff.ly/Mld0vxa #EyeMed

Dr. Christine Parseghian discusses important #CRC research presented at #ASCO25, focusing on studies that are using precision #oncology to drive change in the first-line metastatic setting, such as BREAKWATER. Watch the full video 👉 buff.ly/7GLkSl6 #OncTwitter

Explore biomarker screening approaches to identifying pancreatic ductal adenocarcinoma in people with #diabetes, screening in high-risk groups, and practical strategies for early identification and monitoring. 👉 buff.ly/RJ1sXf1 #OncTwitter #PDAC

From #ASCO25 - CAR T-cell therapy has achieved a significant improvement in progression-free survival for advanced gastric and gastroesophageal junction cancer. Full story 👉 buff.ly/TJo8BgP #MedNews #GastricCancer #CARTCell

#MedNews - Patients with systemic #sclerosis have an increased risk for #CVD and venous thromboembolism before and after diagnosis. Full story 👉 buff.ly/tYfYLef #RheumTwitter

Dr. Namrata Vijayvergia discusses her chosen highlights of the #GICancer presentations from #ASCO25, including the PANOVA-3, DESTINY-Gastric04, and CheckMate 577 trials. Watch the full video 👉 buff.ly/LFleK0X #OncTwitter

From #ASCO25 - Participation in a structured exercise program after adjuvant #chemotherapy for #ColonCancer was associated with a significant survival benefit in the CHALLENGE trial. Full story 👉 buff.ly/3xeFjIl #OncTwitter

#MedCase - Amniotic membrane transplantation is relatively safe but careful management, particularly regarding use of steroid eye drops, is crucial to prevent complications. In this unusual case, C. propinquum caused #keratitis. 👉 buff.ly/Zi71xBT #EyeSurgery #EyeMed

Dr. Maryam Lustberg discusses her selected highlights from the metastatic breast cancer data presented at #ASCO25, including including the INAVO120, DESTINY-Breast09, and ASCENT-04 studies. Watch the full video 👉 buff.ly/JXANcQO #BreastCancer

All you need to know about the current spectrum of injectable therapies in #diabetes care. Understand the types, mechanisms, efficacy, and safety of #insulin and non-insulin injections, in this #EdsChoice review. 👉 buff.ly/jcCitc5 #GLP1 #GLP1RA

From #EULAR2025 - Treatment with the TYK2 inhibitor #deucravacitinib improved disease activity, joint and skin symptoms, and quality of life among people with active #PsoriaticArthritis participating in the POETYK PsA-1 trial. Full story 👉 buff.ly/dtUKqBk #MedNews

#MedNews - In patients with #CKD and type 2 diabetes, #finerenone plus #empagliflozin combination therapy outperforms either monotherapy for UACR reduction. Full story 👉 buff.ly/B7bvKuT #Diabetes #T2D

Join our experts to explore the groundbreaking advances in retinal imaging and gene therapy, before taking a deep dive into emerging treatments for #nAMD 👉 buff.ly/4CCsXfv #EyeMed #RetinalDisease Rigshospitalet Københavns Uni

#MedCase - Neuropsychiatric #SLE and infections, such as #WestNile encephalitis, can be difficult to differentiate, as demonstrated by these cases. This is a vital challenge to overcome due to the opposing management strategies. 👉 buff.ly/kSJYPRj #EdsChoice #Lupus

#MedNews - While #CVD and #cancer are the biggest killers in people with #SLD without cirrhosis, liver-related deaths are most common among those with alcohol use disorder and cirrhosis. Full story 👉 buff.ly/4wPfASI #LiverDisease

Stop by our booth at E17 to learn more about Springer Medicine and how we can support your ongoing medical education. Not able to attend? Find out more about us here 👉 buff.ly/9HeZz1f #EAN2025 #MedEd #NeuroTwitter

Explore the remarkable progress in diagnostic technologies for post-op CNS infections, including molecular assays, metagenomic next-generation sequencing, metabolomics, CRISPR-based pathogen detection, and molecular imaging. 👉 buff.ly/emG4vHq #NeuroTwitter #EdsChoice

#MedNews - Risk of new-onset neovascular age-related macular degeneration in patients with #diabetes more than doubles with use of #GLP1 receptor agonists for 6 months. Full story 👉 buff.ly/UqdYPAB #EyeMed #nAMD

#Dyslipidemia can occur in children under 2 years old, with broad etiology and acute and chronic consequences. Discover the pathophysiology and potential treatment options for dyslipidemia in infants in this #EdsChoice review. 👉 buff.ly/800Crdn #CardioTwitter